naltrexone has been researched along with Fascioliasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azimi, A; Azizi, H; Bazi, A; Khatami, M; Mirzaeei, H; Mirzapour, A; Nahavandi, KH; Nasiri, AA; Yaghoobi, H | 1 |
1 other study(ies) available for naltrexone and Fascioliasis
| Article | Year |
|---|---|
Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Helminth; Enzyme-Linked Immunosorbent Assay; Fasciola hepatica; Fascioliasis; Female; Immunity, Cellular; Immunization; Immunoglobulin G; Interferon-gamma; Interleukin-4; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Naltrexone; Random Allocation; Sheep; Th1 Cells; Viral Vaccines | 2018 |